Cite

HARVARD Citation

    Tuttle, K. et al. (n.d.). MO462: Change in KDIGO Kidney Risk Category With Semaglutide Treatment—A Post Hoc Analysis of the Sustain 6 Trial. Nephrology dialysis transplantation. p. . [Online]. 
  
Back to record